Related Experiment Video
Updated: Jun 29, 2025

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
SMEK1 ablation promotes glucose uptake and improves obesity-related metabolic dysfunction via AMPK signaling pathway
Shijun Wei1, Yu Song1, Zhengbin Li1
1Key Laboratory for Experimental Teratology of the Ministry of Education, Department of Medical Genetics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.
Abstract:
Obesity has become a major risk of global public health. SMEK1 is also known as a regulatory subunit of protein phosphatase 4 (PP4). Both PP4 and SMEK1 have been clarified in many metabolic functions, including the regulation of hepatic gluconeogenesis and glucose transporter gene expression in yeast. Whether SMEK1 participates in obesity and the broader metabolic role in mammals is unknown. Thus, we investigated the function of SMEK1 in white adipose tissue and glucose uptake. GWAS/GEPIA/GEO database was used to analyze the correlation between SMEK1 and metabolic phenotypes/lipid metabolism-related genes/obesity. Smek1 KO mice were generated to identify the role of SMEK1 in obesity and glucose homeostasis. Cell culture and differentiation of stromal-vascular fractions (SVFs) and 3T3-L1 were used to determine the mechanism. 2-NBDG was used to measure the glucose uptake. Compound C was used to confirm the role of AMPK. We elucidated that SMEK1 was correlated with obesity and adipogenesis. Smek1 deletion enhanced adipogenesis in both SVFs and 3T3-L1. Smek1 KO protected mice from obesity and had protective effects on metabolic disorders, including insulin resistance and inflammation. Smek1 KO mice had lower levels of fasting serum glucose. We found that SMEK1 ablation promoted glucose uptake by increasing p-AMPKα(T172) and the transcription of Glut4 when the effect on AMPK-regulated glucose uptake was due to the PP4 catalytic subunits (PPP4C). Our findings reveal a novel role of SMEK1 in obesity and glucose homeostasis, providing a potential new therapeutic target for obesity and metabolic dysfunction.NEW & NOTEWORTHY Our study clarified the relationship between SMEK1 and obesity for the first time and validated the conclusion in multiple ways by combining available data from public databases, human samples, and animal models. In addition, we clarified the role of SMEK1 in glucose uptake, providing an in-depth interpretation for the study of its function in glucose metabolism.
Insights
Smek1 protein is linked to obesity and fat cell development. Removing Smek1 protects mice from obesity and improves glucose metabolism, offering a new target for metabolic disease therapies.
Area of Science:
- Metabolic research
- Molecular biology
- Obesity research
Background:
- Obesity is a significant global health concern.
- SMEK1, a regulatory subunit of protein phosphatase 4 (PP4), has known metabolic functions in yeast.
- The role of SMEK1 in mammalian obesity and metabolism was previously unclear.
Purpose of the Study:
- To investigate the function of SMEK1 in white adipose tissue and glucose uptake in mammals.
- To determine the correlation between SMEK1 and obesity and related metabolic phenotypes.
- To elucidate the molecular mechanisms underlying SMEK1's role in adipogenesis and glucose homeostasis.
Main Methods:
- Analysis of public databases (GWAS, GEPIA, GEO) for SMEK1 correlations.
- Generation and study of Smek1 knockout (KO) mice.
- In vitro studies using stromal-vascular fractions (SVFs) and 3T3-L1 cells for adipogenesis and glucose uptake assays (2-NBDG).
- Pharmacological inhibition of AMPK using Compound C.
Main Results:
- SMEK1 expression is correlated with obesity and adipogenesis.
- Smek1 deletion enhanced adipogenesis in cell models.
- Smek1 KO mice exhibited protection against obesity, insulin resistance, and inflammation, with lower fasting glucose.
- SMEK1 ablation promoted glucose uptake via increased p-AMPKα(T172) and Glut4 transcription, mediated by PP4 catalytic subunits.
Conclusions:
- SMEK1 plays a novel role in regulating obesity and glucose homeostasis in mammals.
- Smek1 deficiency confers protection against metabolic dysfunction.
- Targeting SMEK1 presents a potential therapeutic strategy for obesity and associated metabolic disorders.
More Related Videos
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
Cell Specific Gene Expression
Insulin: The Receptor and Signaling Pathways